Finland· FI-REL-REL22275

Redoxon Plus

A ascorbic acid (vitamin c), combinations product containing ascorbic acid + zinc citrate trihydrate, registered in Finland by Bayer Oy. The same ATC class is registered in 4 of our 19 countries.

ATC A11GB

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRedoxon PlusATCA11GBREGISTER NO.FI-REL-REL22275PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Ascorbic acid + zinc citrate trihydrate is registered in 4 of 19 countries.

Countries holding a registration under ATC A11GB (ascorbic acid (vitamin c), combinations), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 3 of them publish a price we can compare per daily dose

Ascorbic acid + zinc citrate trihydrate · ATC A11GB

4 / 19 countries

  • Finlandprice
  • Ireland
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Ascorbic acid + Zinc citrate trihydrate
Manufacturer
Bayer Oy
Country
Finland (FI)
ATC code
A11GB
ATC class
Ascorbic acid (vitamin C), combinations
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ascorbic acid + zinc citrate trihydrate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ascorbic acid + zinc citrate trihydrate products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Hungary · C-Vitamin/Cink Béres
  • Ireland · Redoxon Double Action

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fbf4c272-dfff-4b52-aef1-1e858384964c
GET /v1/drugs/fbf4c272-dfff-4b52-aef1-1e858384964c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "poretabletti",
  "route": null,
  "ddd_unit": null,
  "strength": "1000 mg",
  "atc_label": "Askorbiinihappoa (C-vitamiini) sisältävät yhdistelmävalmisteet",
  "ma_number": "19944",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL22275",
  "authorised_at": "2005-06-13"
}

See everything about ascorbic acid + zinc citrate trihydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.